Literature DB >> 19176754

Cooperative assembly and misfolding of CFTR domains in vivo.

Kai Du1, Gergely L Lukacs.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) architecture consists of two membrane spanning domains (MSD1 and -2), two nucleotide binding domains (NBD1 and -2), and a regulatory (R) domain. Several point mutations lead to the channel misprocessing, with limited structural perturbation of the mutant domain. To gain more insight into the basis of CFTR folding defect, the contribution of domain-wise and cooperative domain folding was assessed by determining 1) the minimal domain combination that is recognized as native and can efficiently escape the endoplasmic reticulum (ER) retention and 2) the impact of mutation on the conformational coupling among domains. One-, two-, three-, and most of the four-domain assemblies were retained at the ER. Solubilization mutations, however, rescued the NBD1 processing defect conceivably by thermodynamic stabilization. The smallest folding unit that traversed the secretory pathway was composed of MSD1-NBD1-R-MSD2 as a linear or split polypeptide. Cystic fibrosis-causing missense mutations in the MSD1, NBD1, MSD2, and NBD2 caused conformational defect in multiple domains. We propose that cooperative posttranslational folding is required for domain stabilization and provides a plausible explanation for the global misfolding caused by point mutations dispersed along the full-length CFTR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176754      PMCID: PMC2663924          DOI: 10.1091/mbc.e08-09-0950

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  66 in total

1.  Long-range interactions within a nonnative protein.

Authors:  Judith Klein-Seetharaman; Maki Oikawa; Shaun B Grimshaw; Julia Wirmer; Elke Duchardt; Tadashi Ueda; Taiji Imoto; Lorna J Smith; Christopher M Dobson; Harald Schwalbe
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

2.  Co-translational folding of an alphavirus capsid protein in the cytosol of living cells.

Authors:  A V Nicola; W Chen; A Helenius
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

3.  Mapping of interdomain interfaces required for the functional architecture of Yor1p, a eukaryotic ATP-binding cassette (ABC) transporter.

Authors:  Silvere Pagant; Ethan Y Brovman; John J Halliday; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

4.  Domain interactions in the yeast ATP binding cassette transporter Ycf1p: intragenic suppressor analysis of mutations in the nucleotide binding domains.

Authors:  J M Falcón-Pérez; M Martínez-Burgos; J Molano; M J Mazón; P Eraso
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

5.  A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution.

Authors:  L S Ostedgaard; O Baldursson; D W Vermeer; M J Welsh; A D Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation.

Authors:  G C Meacham; C Patterson; W Zhang; J M Younger; D M Cyr
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

Review 7.  CFTR function and prospects for therapy.

Authors:  John R Riordan
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

8.  Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating.

Authors:  Lihua He; Andrei A Aleksandrov; Adrian W R Serohijos; Tamás Hegedus; Luba A Aleksandrov; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

9.  Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2.

Authors:  Meredith F N Rosser; Diane E Grove; Liling Chen; Douglas M Cyr
Journal:  Mol Biol Cell       Date:  2008-08-20       Impact factor: 4.138

10.  Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.

Authors:  K W Chan; L Csanády; D Seto-Young; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

View more
  78 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 2.  hERG quality control and the long QT syndrome.

Authors:  Brian Foo; Brittany Williamson; Jason C Young; Gergely Lukacs; Alvin Shrier
Journal:  J Physiol       Date:  2016-02-09       Impact factor: 5.182

3.  Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.

Authors:  Ori Kalid; Martin Mense; Sharon Fischman; Alina Shitrit; Hermann Bihler; Efrat Ben-Zeev; Nili Schutz; Nicoletta Pedemonte; Philip J Thomas; Robert J Bridges; Diana R Wetmore; Yael Marantz; Hanoch Senderowitz
Journal:  J Comput Aided Mol Des       Date:  2010-10-26       Impact factor: 3.686

4.  Enhancing the Potency of F508del Correction: A Multi-Layer Combinational Approach to Drug Discovery for Cystic Fibrosis.

Authors:  Emily F Kirby; Ashley S Heard; X Robert Wang
Journal:  J Pharmacol Clin Toxicol       Date:  2013-08-28

Review 5.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.

Authors:  Carlos M Farinha; Sara Canato
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

6.  Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.

Authors:  Puay-Wah Phuan; Jung-Ho Son; Joseph-Anthony Tan; Clarabella Li; Ilaria Musante; Lorna Zlock; Dennis W Nielson; Walter E Finkbeiner; Mark J Kurth; Luis J Galietta; Peter M Haggie; Alan S Verkman
Journal:  J Cyst Fibros       Date:  2018-06-12       Impact factor: 5.482

7.  Regulation of activation and processing of the cystic fibrosis transmembrane conductance regulator (CFTR) by a complex electrostatic interaction between the regulatory domain and cytoplasmic loop 3.

Authors:  Guangyu Wang; Dayue Darrel Duan
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

8.  The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.

Authors:  Hanneke Hoelen; Bertrand Kleizen; Andre Schmidt; John Richardson; Paraskevi Charitou; Philip J Thomas; Ineke Braakman
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

10.  Interplay between ER exit code and domain conformation in CFTR misprocessing and rescue.

Authors:  Gargi Roy; Elaine M Chalfin; Anita Saxena; Xiaodong Wang
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.